Animalcare Group Past Earnings Performance
Past criteria checks 4/6
Animalcare Group has been growing earnings at an average annual rate of 68.1%, while the Pharmaceuticals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 0.6% per year. Animalcare Group's return on equity is 4.8%, and it has net margins of 6.1%.
Key information
68.1%
Earnings growth rate
68.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 7.3% |
| Revenue growth rate | 0.6% |
| Return on equity | 4.8% |
| Net Margin | 6.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Animalcare Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 76 | 5 | 36 | 3 |
| 31 Mar 24 | 75 | 3 | 35 | 3 |
| 31 Dec 23 | 74 | 1 | 35 | 3 |
| 30 Sep 23 | 71 | 1 | 33 | 3 |
| 30 Jun 23 | 69 | 1 | 32 | 3 |
| 31 Mar 23 | 70 | 2 | 32 | 3 |
| 31 Dec 22 | 72 | 2 | 32 | 3 |
| 30 Sep 22 | 72 | 2 | 32 | 3 |
| 30 Jun 22 | 73 | 2 | 31 | 3 |
| 31 Mar 22 | 74 | 1 | 31 | 3 |
| 31 Dec 21 | 74 | 0 | 31 | 3 |
| 30 Sep 21 | 75 | 0 | 31 | 3 |
| 30 Jun 21 | 75 | 0 | 32 | 4 |
| 31 Mar 21 | 73 | 0 | 31 | 4 |
| 31 Dec 20 | 70 | 0 | 30 | 3 |
| 30 Sep 20 | 70 | 0 | 30 | 4 |
| 30 Jun 20 | 70 | 1 | 29 | 4 |
| 31 Mar 20 | 70 | 0 | 29 | 4 |
| 31 Dec 19 | 71 | -1 | 29 | 4 |
| 30 Sep 19 | 72 | -2 | 29 | 4 |
| 30 Jun 19 | 73 | -3 | 29 | 5 |
| 31 Mar 19 | 73 | -1 | 29 | 5 |
| 31 Dec 18 | 72 | 0 | 29 | 5 |
| 30 Sep 18 | 72 | 0 | 30 | 4 |
| 30 Jun 18 | 72 | 0 | 30 | 4 |
| 31 Mar 18 | 67 | 0 | 28 | 3 |
| 31 Dec 17 | 62 | 0 | 26 | 3 |
| 31 Dec 16 | 68 | 4 | 22 | 2 |
| 31 Dec 15 | 47 | -1 | 15 | 1 |
| 31 Dec 14 | 34 | 1 | 8 | 0 |
Quality Earnings: WQ7 has a large one-off gain of £2.3M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: WQ7's current net profit margins (6.1%) are higher than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WQ7 has become profitable over the past 5 years, growing earnings by 68.1% per year.
Accelerating Growth: WQ7's earnings growth over the past year (275.5%) exceeds its 5-year average (68.1% per year).
Earnings vs Industry: WQ7 earnings growth over the past year (275.5%) exceeded the Pharmaceuticals industry 1.5%.
Return on Equity
High ROE: WQ7's Return on Equity (4.8%) is considered low.